CLINICAL_TRIALS
trial_result
· 2025-08-22
Clinical Trial Update: A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis [Phase 2]
Summary
Phase 2 proof-of-concept trial evaluating Nipocalimab for active rheumatoid arthritis, with posted efficacy and safety results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2025-08-22